Result of AGM
Diaceutics PLC announced that all resolutions proposed at its Annual General Meeting on June 25, 2026, were duly passed by shareholders. The financial statements for the year ended December 31, 2025, were received with 99.99% of votes in favour. The directors' remuneration report was approved with 97.33% of votes for. Re-elections of directors Graham Paterson, Peter Keeling, Ryan Keeling, Nick Roberts, Jordan Clark, and Cheryl MacDiarmid all received substantial support, ranging from 86.38% to 99.22% of votes cast. Ernst & Young was re-appointed as auditors with 99.92% of votes in favour, and the directors were authorized to determine auditor remuneration and allot ordinary shares, with both resolutions passing with over 99.98% of votes. The company also received strong approval for its special resolution to dis-apply statutory pre-emption rights (99.96%) and to make market purchases of its ordinary shares (99.99%).
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
New York, Belfast and London, 25 June 2026 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, is pleased to announce that all resolutions proposed at its Annual General Meeting held earlier today, were duly passed. The proxy votes received from shareholders in respect of each resolution are set out below and are available on the Company's website www.diaceutics.com
| Resolution | For (excluding at Chair's discretion) | Against | Total votes cast | Withheld | |||
|---|---|---|---|---|---|---|---|
| Number of votes | % | Number of votes | % | Number of votes | Number of votes | ||
| 1 | Ordinary resolution to receive To receive and consider the Company's financial statements for the financial year ended 31 December 2025 together with the directors' report and the auditors' report on those annual accounts | 53,917,796 | 99.99 | 7,000 | 0.01 | 53,924,796 | 207 |
| 2 | Ordinary resolution to approve the directors' remuneration report | 52,481,617 | 97.33 | 1,441,199 | 2.67 | 53,922,816 | 2,187 |
| 3 | Ordinary resolution to re-elect Graham Paterson as a director of the Company | 48,829,837 | 93.02 | 3,662,479 | 6.98 | 52,492,316 | 1,432,687 |
| 4 | Ordinary resolution to re-elect Peter Keeling as a director of the Company | 46,579,688 | 86.38 | 7,343,128 | 13.62 | 53,922,816 | 2,187 |
| 5 | Ordinary resolution to re-elect Ryan Keeling as a director of the Company | 51,859,014 | 96.17 | 2,063,802 | 3.83 | 53,922,816 | 2,187 |
| 6 | Ordinary resolution to re-elect Nick Roberts as a director of the Company | 51,859,014 | 96.17 | 2,063,711 | 3.83 | 53,922,725 | 2,278 |
| 7 | Ordinary resolution to re-elect Jordan Clark as a director of the Company | 51,859,014 | 96.17 | 2,063,711 | 3.83 | 53,922,725 | 2,278 |
| 8 | Ordinary resolution to re-elect Cheryl MacDiarmid as a director of the Company | 53,501,672 | 99.22 | 421,053 | 0.78 | 53,922,725 | 2,278 |
| 9 | Ordinary resolution to re-appoint Ernst & Young as auditors of the Company | 53,878,631 | 99.92 | 44,186 | 0.08 | 53,922,817 | 2,186 |
| 10 | Ordinary resolution to authorise the directors to determine the remuneration of the auditors | 53,912,118 | 99.98 | 10,699 | 0.02 | 53,922,817 | 2,186 |
| 1 1 | Ordinary resolution to authorise the directors to allot ordinary shares | 53,915,269 | 99.99 | 7,213 | 0.01 | 53,922,482 | 2,521 |
| 12 | Special resolution to authorise the directors to dis-apply statutory pre-emption rights pursuant to section 570 of the Companies Act 2006 | 53,895,048 | 99.96 | 23,948 | 0.04 | 53,918,996 | 6,007 |
| 13 | Special resolution to authorise the directors to make market purchase of its ordinary shares | 51,491,743 | 99.99 | 6,099 | 0.01 | 51,497,842 | 2,427,161 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.